To determine if increased CD36 expression results in metabolic changes, we used the GO-lipid metabolic process gene list present in the molecular signature database (MSigDB) to generate a correlation matrix for increased CD36 expression in the TCGA breast cancer patient dataset. Here, CD36 is linked to breast cancer.